thiorphan has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanović, S | 1 |
| Boranić, M | 1 |
| Petrovecki, M | 1 |
| Batinić, D | 1 |
| Skodlar, J | 1 |
| Nemet, D | 1 |
| Labar, B | 1 |
| Arock, M | 1 |
| Gros, C | 1 |
| Devillier, P | 1 |
| Guillosson, JJ | 1 |
| Schwartz, JC | 1 |
2 other studies available for thiorphan and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Angiotensin-Converting Enzyme Inhibitors; | 2000 |
Characterisation of enkephalinase (EC 3.4.24.11) activity on various leukemic cells expressing the common acute lymphocytic leukemia antigen (CALLA).
Topics: Antigens, Differentiation; Antigens, Neoplasm; Bone Marrow; Cell Division; Cell Line; Cell Membrane; | 1989 |